TP53 and cancer: CDK1 represents a core component of the cell cycle and forms complexes with cyclin A and cyclin B to promote cell cycle progression from S to G2/M phase [57, 58] and unlike normal cells, cancer cells are highly dependent on G2/M checkpoint for genomic damage repair broadly due to a defective p53-dependent G1/S checkpoint that is inherent for cancer development [59].